Treatment of exacerbations of post-traumatic stress disorder by short-term dexamethasone, a pilot study.
- Conditions
- Posttraumatic stress syndrome F431
- Registration Number
- EUCTR2010-018486-37-SE
- Lead Sponsor
- Kris-och Traumacentrum
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Authorised-recruitment may be ongoing or finished
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
Excacerbation in chronic ptsd with marked flash-backs.
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range
Exclusion Criteria
1.Suicidal risk
2.Bipolar disease
3.Psycosis with lack of reality testning
4.Aggression
5.Sociopati
6.Infection
7.Untreated ulcus
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Main Objective: Investigate if dexamethasone-treatment reduces symtoms in patients with excacerbation of chronic ptsd.;Secondary Objective: Investigate if dexamethasone-treatment reduces symtoms related to depression and dissociation. <br><br>;Primary end point(s): Changes in self evaluation scores of PTSD-symtoms (Davidson Trauma Scale).
- Secondary Outcome Measures
Name Time Method